Kabra Drugs Market Cap

Kabra Drugs has a market cap or net worth of 669.27 million as of April 17, 2026. Its market cap has increased by 2,126.31% in one year.

Market Cap

669.27M

Enterprise Value

556.98M

Revenue

573.34M

Ranking

n/a

PE Ratio

13.88

Stock Price

28.23

Market Cap Chart

Since May 17, 2001, Kabra Drugs's market cap has increased from 7.46M to 669.27M, an increase of 8,870.74%. That is a compound annual growth rate of 19.76%.

Market Cap History

Date	Market Cap	% Change
Apr 17, 2026	669.27M	-7.59%
Dec 31, 2025	724.27M	614.30%
Dec 30, 2024	101.40M	328.65%
Dec 26, 2023	23.65M	21.67%
Dec 30, 2022	19.44M	-11.40%
Dec 27, 2021	21.94M	15.21%
Dec 28, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 26, 2017	Upgrade Pro	Upgrade Pro
Dec 28, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
ASL Industries	969.31M
Paras Petrofils	788.76M
Maha Rashtra Apex Corporation	721.08M
IB Infotech Enterprises	673.98M
Modern Engineering and Projects	625.57M
Modipon	478.00M
Lerthai Finance	459.80M
Magnus Steel and Infra	446.74M

Market Cap Rankings